Best compounded tirzepatide prescribers
Tirzepatide alone.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.
31 sellers are partners on this board today, sorted first and labeled Partner — the one respect in which the ordering is commercial. Every other seller here is ranked purely on the published rubric, which cannot see commercial status either way.
The board at a glance
- 175 sellers are on the tirzepatide board; 81 of them name their compounding pharmacy, and 23 require a consultation before any prescription.
- The lowest monthly cost in this board's scope is $86 a month with the required membership (our total; the seller prints $69/mo), for Tirzepatide injection at Collective; price is 6% of the order here, so it does not decide the rank.
What the evidence says, before the sellers
- TirzepatideFDA-approved
Large trials for weight. 1 randomized trial of 1,000 or more people cited here for weight.
Both trials used the approved product. Neither tested a compounded preparation, so the numbers describe Zepbound, not a pharmacy's version of it.
The ranking
Each seller below prescribes tirzepatide and has a full review on this site; compare the first six below, then expand another group for more providers.
These service details do not establish treatment effectiveness. Read the assessments below for the evidence, pharmacy information and published prices.
- Rank01
SkinnyRxPartner
SkinnyRx is first on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board SkinnyRx is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank02
LttlPartner
Lttl is second on the tirzepatide board, carried by its follow-up mark and its price as the dose rises mark; its weakest mark here is stays within legal scope.
- What it prices here
- Tirzepatide injection (compounded)from $149 per 4 wks$161 a calendar month, our arithmetic
- Prescriber and intake
- Names no prescriber; a questionnaire, with no live visit mentioned
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Also lists MOTS-c, BPC-157, Epitalon, TB-500, KPV, Semax, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Lttl is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank03
OakPartner
Oak is third on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)from $250/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
On the tirzepatide board Oak is read on 70% of the rubric's weight: follow-up and state coverage are left out of its order, not counted against it.
- Rank04
GalaPartner
Gala is fourth on the tirzepatide board, carried by its follow-up mark and its stays within legal scope mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)from $179/mo
- Prescriber and intake
- Names no prescriber
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Gala is read on 75% of the rubric's weight: dosing guidance is left out of its order, not counted against it.
- Rank05
EdenPartner
Eden is fifth on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)from $199/mo$298 a month with the required membership, our total
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank06
YourEraPartner
YourEra is sixth on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Tirzepatide injection (compounded)from $199 per 4 wks$216 a calendar month, our arithmetic
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board YourEra is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
Compare providers 7–18HumeCare+, Direct Meds, Found, Sprout Health, TMates, PeterMD, Embody, SnagRx, MEDGm, HealthRX, Strut Health, CoreAge Rx
- Rank07
HumeCare+Partner
HumeCare+ is seventh on the tirzepatide board, carried by its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names no prescriber; a consultation before any prescription
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board HumeCare+ is read on 60% of the rubric's weight: stays within legal scope, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank08
Direct MedsPartner
Direct Meds is eighth on the tirzepatide board; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)from $399/mo
- Tirzepatide sublingual (compounded)from $299/mo
- Prescriber and intake
- Names no prescriber
- Pharmacy named
- Not recorded: our review found no answer on its pages
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Also lists BPC-157, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Direct Meds is read on 40% of the rubric's weight: pharmacy named, dosing guidance, follow-up, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank09
FoundPartner
Found is ninth on the tirzepatide board, carried by its follow-up mark and its state coverage mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)from $359 for 4 weeks$389 a calendar month, our arithmetic
- Prescriber and intake
- Names no prescriber
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Found is read on 70% of the rubric's weight: stays within legal scope and price as the dose rises are left out of its order, not counted against it.
- Rank10
Sprout HealthPartner
Sprout Health is tenth on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)from $349 per 4 wks$378 a calendar month, our arithmetic
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 44 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Sprout Health is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank11
TMatesPartner
TMates is number 11 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $297/mo
- Prescriber and intake
- Names no prescriber; a consultation before any prescription
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank12
PeterMDPartner
PeterMD is number 12 on the tirzepatide board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Prescriber and intake
- Names no prescriber; a consultation before any prescription
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 42 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board PeterMD is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank13
EmbodyPartner
Embody is number 13 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Tirzepatide oral (compounded)price not published
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Embody is read on 70% of the rubric's weight: dosing guidance and price as the dose rises are left out of its order, not counted against it.
- Rank14
SnagRxPartner
SnagRx is number 14 on the tirzepatide board, carried by its follow-up mark and its price as the dose rises mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $149/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with no live visit mentioned
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board SnagRx is read on 70% of the rubric's weight: stays within legal scope and state coverage are left out of its order, not counted against it.
- Rank15
MEDGmPartner
MEDGm is number 15 on the tirzepatide board, carried by its follow-up mark and its state coverage mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)from $399/mo
- Prescriber and intake
- Names no prescriber
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board MEDGm is read on 70% of the rubric's weight: stays within legal scope and price as the dose rises are left out of its order, not counted against it.
- Rank16
HealthRXPartner
HealthRX is number 16 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)from $214/mo
- Prescriber and intake
- Names no prescriber
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board HealthRX is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank17
Strut HealthPartner
Strut Health is number 17 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $149/mo
- Tirzepatide sublingual (compounded)from $199/mo
- Prescriber and intake
- Names one prescribing physician; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 49 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Strut Health is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank18
CoreAge RxPartner
CoreAge Rx is number 18 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $149/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board CoreAge Rx is read on 75% of the rubric's weight: dosing guidance is left out of its order, not counted against it.
Compare providers 19–30Enhance MD, Live Vital, DudeMeds, RxSpan MD, Sesame Care, Bodybuilding Health+, Luvo Health, bmiMD, Collective, Willow, RNK Health, Wellorithm
- Rank19
Enhance MDPartner
Enhance MD is number 19 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $329 per 4 wks$356 a calendar month, our arithmetic
- Prescriber and intake
- Names no prescriber; a consultation before any prescription
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 39 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank20
Live VitalPartner
Live Vital is number 20 on the tirzepatide board, carried by its follow-up mark and its state coverage mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names one prescribing physician; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Also lists MOTS-c, which no pharmacy may lawfully compound
- State coverage
- All 50 states
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Live Vital is read on 65% of the rubric's weight: dosing guidance, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank21
DudeMedsPartner
DudeMeds is number 21 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $433/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board DudeMeds is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank22
RxSpan MDPartner
RxSpan MD is number 22 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $329/mo
- Tirzepatide oral (compounded)from $349/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board RxSpan MD is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank23
Sesame CarePartner
Sesame Care is number 23 on the tirzepatide board, carried by its prescriber and intake mark and its follow-up mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (brand)from $299/mo$398 a month with the required membership, our total
- Prescriber and intake
- Names its physician network; a consultation before any prescription
- Pharmacy named
- Not recorded: our review found no answer on its pages
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Price rises with the dose
On the tirzepatide board Sesame Care is read on 45% of the rubric's weight: pharmacy named, dosing guidance, stays within legal scope and state coverage are left out of its order, not counted against it.
- Rank24
Bodybuilding Health+Partner
Bodybuilding Health+ is number 24 on the tirzepatide board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)from $319/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Bodybuilding Health+ is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank25
Luvo HealthPartner
Luvo Health is number 25 on the tirzepatide board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)from $249 per 4 wks$270 a calendar month, our arithmetic
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Luvo Health is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank26
bmiMDPartner
bmiMD is number 26 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)from $249 per 4 wks$270 a calendar month, our arithmetic
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank27
CollectivePartner
Collective is number 27 on the tirzepatide board, carried by its prescriber and intake mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $69/mo$86 a month with the required membership, our total
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- 44 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Collective is read on 75% of the rubric's weight: stays within legal scope is left out of its order, not counted against it.
- Rank28
WillowPartner
Willow is number 28 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $399/mo
- Tirzepatide sublingual (compounded)from $399/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with no live visit mentioned
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Willow is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank29
RNK HealthPartner
RNK Health is number 29 on the tirzepatide board, carried by its prescriber and intake mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $297/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board RNK Health is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank30
WellorithmPartner
Wellorithm is number 30 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $349 per 4 wks$378 a calendar month, our arithmetic
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Wellorithm is read on 75% of the rubric's weight: dosing guidance is left out of its order, not counted against it.
Compare providers 31–42MyDrHank, Klarity Health, PlexusDx, NowPatient, Contour Health, Care Bare Rx, CVS MinuteClinic, Form Health, MD Live, MEDvidi, Try Ageless, EOS Health
- Rank31
MyDrHankPartner
MyDrHank is number 31 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $240/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with no live visit mentioned
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board MyDrHank is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank32
Klarity Health
Klarity Health is number 32 on the tirzepatide board, carried by its prescriber and intake mark and its follow-up mark.
- What it prices here
Tirzepatide is on Klarity Health's own list with no price we hold.
- Prescriber and intake
- Names its prescribing doctors; a consultation before any prescription
- Pharmacy named
- Not recorded: our review found no answer on its pages
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Klarity Health is read on 45% of the rubric's weight: pharmacy named, dosing guidance, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank33
PlexusDx
PlexusDx is number 33 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $289/mo
- Tirzepatide oral (compounded)from $349/mo
- Prescriber and intake
- Names its prescribing doctors
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board PlexusDx is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank34
NowPatient
NowPatient is number 34 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (brand)from $251.98/mo$327 a month with the required shipping, our total
- Prescriber and intake
- A consultation before any prescription
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board NowPatient is read on 65% of the rubric's weight: stays within legal scope, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank35
Contour Health
Contour Health is number 35 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price as the dose rises.
- What it prices here
- Tirzepatide injection (compounded)from $200 per 4 wks$217 a calendar month, our arithmetic
- Prescriber and intake
- Names its prescribing doctors; a consultation before any prescription
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
On the tirzepatide board Contour Health is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank36
Care Bare Rx
Care Bare Rx is number 36 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price as the dose rises.
- What it prices here
- Tirzepatide injection (compounded)from $199/mo
- Prescriber and intake
- Names its prescribing doctors; a consultation before any prescription
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
On the tirzepatide board Care Bare Rx is read on 65% of the rubric's weight: dosing guidance and follow-up are left out of its order, not counted against it.
- Rank37
CVS MinuteClinic
CVS MinuteClinic is number 37 on the tirzepatide board, carried by its prescriber and intake mark and its follow-up mark.
- What it prices here
Tirzepatide is on CVS MinuteClinic's own list with no price we hold.
- Prescriber and intake
- Names its physician network; a consultation before any prescription
- Pharmacy named
- Not recorded: our review found no answer on its pages
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board CVS MinuteClinic is read on 45% of the rubric's weight: pharmacy named, dosing guidance, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank38
Form Health
Form Health is number 38 on the tirzepatide board, carried by its prescriber and intake mark and its follow-up mark.
- What it prices here
Tirzepatide is on Form Health's own list with no price we hold.
- Prescriber and intake
- Names its physician network; a consultation before any prescription
- Pharmacy named
- Not recorded: our review found no answer on its pages
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Form Health is read on 45% of the rubric's weight: pharmacy named, dosing guidance, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank39
MD Live
MD Live is number 39 on the tirzepatide board, carried by its prescriber and intake mark and its follow-up mark.
- What it prices here
Tirzepatide is on MD Live's own list with no price we hold.
- Prescriber and intake
- Names its physician network; a consultation before any prescription
- Pharmacy named
- Not recorded: our review found no answer on its pages
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board MD Live is read on 45% of the rubric's weight: pharmacy named, dosing guidance, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank40
MEDvidi
MEDvidi is number 40 on the tirzepatide board, carried by its prescriber and intake mark and its follow-up mark.
- What it prices here
Tirzepatide is on MEDvidi's own list with no price we hold.
- Prescriber and intake
- Names its physician network; a consultation before any prescription
- Pharmacy named
- Not recorded: our review found no answer on its pages
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board MEDvidi is read on 45% of the rubric's weight: pharmacy named, dosing guidance, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank41
Try Ageless
Try Ageless is number 41 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Tirzepatide injection (compounded)from $169/mo
- Tirzepatide sublingual (compounded)from $249/mo
- Tirzepatide oral (compounded)from $289/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Try Ageless is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank42
EOS Health
EOS Health is number 42 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Prescriber and intake
- Not recorded: our review found no answer on its pages
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 40 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board EOS Health is read on 40% of the rubric's weight: prescriber and intake, dosing guidance and follow-up are left out of its order, not counted against it.
Compare providers 43–54Synergy Rx, RxSaludable, Levers Health, Renlo Health, FuturHealth, Ivologist, Obu Health, Kova, Medro, Enhanced, REMEVi, Effecty
- Rank43
Synergy Rx
Synergy Rx is number 43 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $349/mo
- Tirzepatide sublingual (compounded)price not published
- Tirzepatide injection (brand)from $947/mo
- Prescriber and intake
- Names its prescribing doctors; a consultation before any prescription
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Synergy Rx is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank44
RxSaludable
RxSaludable is number 44 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names its prescribing doctors
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Same price at every dose
On the tirzepatide board RxSaludable is read on 75% of the rubric's weight: state coverage and price against the market are left out of its order, not counted against it.
- Rank45
Levers Health
Levers Health is number 45 on the tirzepatide board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is price as the dose rises.
- What it prices here
- Tirzepatide injection (compounded)from $296/mo
- Prescriber and intake
- Not recorded: our review found no answer on its pages
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Price rises with the dose
On the tirzepatide board Levers Health is read on 55% of the rubric's weight: prescriber and intake and state coverage are left out of its order, not counted against it.
- Rank46
Renlo Health
Renlo Health is number 46 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $269/mo
- Prescriber and intake
- Names its prescribing doctors
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank47
FuturHealth
FuturHealth is number 47 on the tirzepatide board, carried by its prescriber and intake mark and its stays within legal scope mark.
- What it prices here
Tirzepatide is on FuturHealth's own list with no price we hold.
- Prescriber and intake
- Names its physician network; a consultation before any prescription
- Pharmacy named
- Not recorded: our review found no answer on its pages
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board FuturHealth is read on 50% of the rubric's weight: pharmacy named, dosing guidance, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank48
Ivologist
Ivologist is number 48 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Tirzepatide injection (compounded)from $249/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Also lists BPC-157, which no pharmacy may lawfully compound
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Ivologist is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank49
Obu Health
Obu Health is number 49 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Tirzepatide injection (compounded)from $239/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Obu Health is read on 70% of the rubric's weight: dosing guidance and state coverage are left out of its order, not counted against it.
- Rank50
Kova
Kova is number 50 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
Tirzepatide is on Kova's own list with no price we hold.
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Kova is read on 65% of the rubric's weight: dosing guidance, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank51
Medro
Medro is number 51 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Medro is read on 60% of the rubric's weight: dosing guidance, follow-up and price as the dose rises are left out of its order, not counted against it.
- Rank52
Enhanced
Enhanced is number 52 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark.
- What it prices here
- Tirzepatide injection (compounded)from $129/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Enhanced is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank53
REMEVi
REMEVi is number 53 on the tirzepatide board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $269 per 4 wks$291 a calendar month, our arithmetic
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board REMEVi is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank54
Effecty
Effecty is number 54 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Tirzepatide injection (compounded)from $235/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
Compare providers 55–66Hims, Nova MD, Trimi Health, ARSYNL Rx, Bloom MD, Midi Health, Avono Health, Fridays, Vyora Wellness, Vita Bella, Get Thin MD, Zenbody
- Rank55
Hims
Hims is number 55 on the tirzepatide board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (brand)from $299/mo$448 a month with the required membership, our total
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Hims is read on 65% of the rubric's weight: stays within legal scope, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank56
Nova MD
Nova MD is number 56 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price as the dose rises.
- What it prices here
- Tirzepatide injection (compounded)from $199/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
On the tirzepatide board Nova MD is read on 70% of the rubric's weight: dosing guidance and state coverage are left out of its order, not counted against it.
- Rank57
Trimi Health
Trimi Health is number 57 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)from $235/mo
- Prescriber and intake
- Names its prescribing doctors
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Trimi Health is read on 75% of the rubric's weight: stays within legal scope is left out of its order, not counted against it.
- Rank58
ARSYNL Rx
ARSYNL Rx is number 58 on the tirzepatide board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $269/mo
- Tirzepatide topical (compounded)from $269/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board ARSYNL Rx is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank59
Bloom MD
Bloom MD is number 59 on the tirzepatide board, carried by its pharmacy named mark and its dosing guidance mark.
- What it prices here
- Tirzepatide injection (compounded)from $249/mo
- Prescriber and intake
- Names one prescribing physician; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Bloom MD is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank60
Midi Health
Midi Health is number 60 on the tirzepatide board, carried by its prescriber and intake mark and its dosing guidance mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $210 per 4 wks$228 a calendar month, our arithmetic
- Tirzepatide sublingual (compounded)from $209 per 4 wks$226 a calendar month, our arithmetic
- Prescriber and intake
- A consultation before any prescription
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Midi Health is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank61
Avono Health
Avono Health is number 61 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Tirzepatide oral (compounded)from $349/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Avono Health is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank62
Fridays
Fridays is number 62 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $359/mo
- Tirzepatide injection (brand)from $1,828/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Fridays is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank63
Vyora Wellness
Vyora Wellness is number 63 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $399/mo
- Tirzepatide oral (compounded)from $359/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Vyora Wellness is read on 60% of the rubric's weight: dosing guidance, follow-up and state coverage are left out of its order, not counted against it.
- Rank64
Vita Bella
Vita Bella is number 64 on the tirzepatide board, carried by its prescriber and intake mark and its dosing guidance mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $159/mo$288 a month with the required membership, our total
- Prescriber and intake
- A consultation before any prescription
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 48 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Vita Bella is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank65
Get Thin MD
Get Thin MD is number 65 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank66
Zenbody
Zenbody is number 66 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Tirzepatide oral (compounded)price not published
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Zenbody is read on 60% of the rubric's weight: stays within legal scope, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
Compare providers 67–78Trellis Vitality, MadeMed, Vytora Health, Evernow, Revive Longevity, Woodwork, Lean Meds, 50 Stars Health, RxION Health, Nu Image Medical, VigorMeds, Welludr
- Rank67
Trellis Vitality
Trellis Vitality is number 67 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)from $199/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Trellis Vitality is read on 75% of the rubric's weight: follow-up is left out of its order, not counted against it.
- Rank68
MadeMed
MadeMed is number 68 on the tirzepatide board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Tirzepatide sublingual (compounded)price not published
- Prescriber and intake
- Names one prescribing physician; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board MadeMed is read on 70% of the rubric's weight: state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank69
Vytora Health
Vytora Health is number 69 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark.
- What it prices here
- Tirzepatide injection (compounded)from $249/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Vytora Health is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank70
Evernow
Evernow is number 70 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark.
- What it prices here
Tirzepatide is on Evernow's own list with no price we hold.
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Not recorded: our review found no answer on its pages
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Evernow is read on 45% of the rubric's weight: pharmacy named, dosing guidance, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank71
Revive Longevity
Revive Longevity is number 71 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank72
Woodwork
Woodwork is number 72 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Tirzepatide injection (compounded)from $199/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Woodwork is read on 65% of the rubric's weight: follow-up, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank73
Lean Meds
Lean Meds is number 73 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)from $129/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
- Rank74
50 Stars Health
50 Stars Health is number 74 on the tirzepatide board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)from $220/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board 50 Stars Health is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank75
RxION Health
RxION Health is number 75 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Tirzepatide injection (brand)from $1,259/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board RxION Health is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank76
Nu Image Medical
Nu Image Medical is number 76 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $289/mo
- Tirzepatide oral (compounded)from $314/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Nu Image Medical is read on 65% of the rubric's weight: follow-up, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank77
VigorMeds
VigorMeds is number 77 on the tirzepatide board, carried by its prescriber and intake mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)from $399/mo
- Tirzepatide sublingual (compounded)from $233/mo
- Prescriber and intake
- Names its prescribing doctors
- Pharmacy named
- Not recorded: our review found no answer on its pages
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board VigorMeds is read on 60% of the rubric's weight: pharmacy named, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank78
Welludr
Welludr is number 78 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Tirzepatide oral (compounded)price not published
- Tirzepatide injection (brand)from $1,599/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Welludr is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
Compare providers 79–90PepHaūs, Brello Health, EdgeRx, Raeliva, Kongo, PauseRX, Jently, Auren Rx, Pallas Health, Whoosh Wellness, Invigor Medical, Nurx
- Rank79
PepHaūs
PepHaūs is number 79 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)from $239/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board PepHaūs is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank80
Brello Health
Brello Health is number 80 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 41 states
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Brello Health is read on 75% of the rubric's weight: price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank81
EdgeRx
EdgeRx is number 81 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark.
- What it prices here
- Tirzepatide injection (compounded)from $225/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists Oxytocin, which no pharmacy may lawfully compound
- State coverage
- 46 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board EdgeRx is read on 70% of the rubric's weight: dosing guidance and price as the dose rises are left out of its order, not counted against it.
- Rank82
Raeliva
Raeliva is number 82 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Tirzepatide sublingual (compounded)from $359/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Raeliva is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank83
Kongo
Kongo is number 83 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark.
- What it prices here
- Tirzepatide injection (compounded)from $229/mo
- Prescriber and intake
- Names one prescribing physician; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
- Rank84
PauseRX
PauseRX is number 84 on the tirzepatide board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)from $249/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board PauseRX is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank85
Jently
Jently is number 85 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $259/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Jently is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank86
Auren Rx
Auren Rx is number 86 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark.
- What it prices here
- Tirzepatide injection (compounded)from $229/mo
- Prescriber and intake
- Names one prescribing physician
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Auren Rx is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank87
Pallas Health
Pallas Health is number 87 on the tirzepatide board, carried by its prescriber and intake mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $299 per 4 wks$324 a calendar month, our arithmetic
- Prescriber and intake
- Names its prescribing doctors
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Pallas Health is read on 75% of the rubric's weight: dosing guidance is left out of its order, not counted against it.
- Rank88
Whoosh Wellness
Whoosh Wellness is number 88 on the tirzepatide board, carried by its pharmacy named mark and its follow-up mark.
- What it prices here
- Tirzepatide injection (compounded)from $249/mo
- Tirzepatide oral (compounded)from $249/mo
- Prescriber and intake
- Names one prescribing physician
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Whoosh Wellness is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank89
Invigor Medical
Invigor Medical is number 89 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (compounded)from $350 per 4 wks$379 a calendar month, our arithmetic
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Invigor Medical is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank90
Nurx
Nurx is number 90 on the tirzepatide board, carried by its prescriber and intake mark and its stays within legal scope mark; its weakest mark here is price against the market.
- What it prices here
- Tirzepatide injection (brand)from $349/mo$428 a month with the required membership, our total
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Not recorded: our review found no answer on its pages
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Price rises with the dose
On the tirzepatide board Nurx is read on 55% of the rubric's weight: pharmacy named, dosing guidance and state coverage are left out of its order, not counted against it.
Compare providers 91–102PreventiveMD, iThriveMD, Yucca Health, Pepti, Idgie Health, The Edit, Breeze Meds, Heally, ZYP Medical, Ivim Health, Heros Health, PrescrYbe
- Rank91
PreventiveMD
PreventiveMD is number 91 on the tirzepatide board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)from $139/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 36 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board PreventiveMD is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank92
iThriveMD
iThriveMD is number 92 on the tirzepatide board, carried by its prescriber and intake mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $399 per 4 wks$432 a calendar month, our arithmetic
- Prescriber and intake
- Names its prescribing doctors
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board iThriveMD is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank93
Yucca Health
Yucca Health is number 93 on the tirzepatide board, carried by its prescriber and intake mark and its dosing guidance mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $258/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank94
Pepti
Pepti is number 94 on the tirzepatide board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is stays within legal scope.
- What it prices here
- Tirzepatide injection (compounded)from $159 per 4 wks$172 a calendar month, our arithmetic
- Tirzepatide oral (compounded)price not published
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists MOTS-c, BPC-157, Ipamorelin, Epitalon, TB-500, Retatrutide, KPV, Semax, which no pharmacy may lawfully compound
- State coverage
- 36 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
- Rank95
Idgie Health
Idgie Health is number 95 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)from $179/mo
- Tirzepatide injection (compounded)from $229/mo
- Tirzepatide oral (compounded)from $287/mo
- Prescriber and intake
- Names one prescribing physician; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
- Rank96
The Edit
The Edit is number 96 on the tirzepatide board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)from $349/mo
- Prescriber and intake
- A questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank97
Breeze Meds
Breeze Meds is number 97 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Tirzepatide oral (compounded)from $399/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Breeze Meds is read on 70% of the rubric's weight: follow-up and price as the dose rises are left out of its order, not counted against it.
- Rank98
Heally
Heally is number 98 on the tirzepatide board, carried by its prescriber and intake mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (brand)from $299/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Heally is read on 70% of the rubric's weight: dosing guidance and price as the dose rises are left out of its order, not counted against it.
- Rank99
ZYP Medical
ZYP Medical is number 99 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is stays within legal scope.
- What it prices here
- Tirzepatide injection (compounded)from $299 per 4 wks$324 a calendar month, our arithmetic
- Tirzepatide sublingual (compounded)from $250/mo
- Prescriber and intake
- Names one prescribing physician; a consultation before any prescription
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Also lists BPC-157, CJC-1295, Ipamorelin, TB-500, KPV, 5-Amino-1MQ, which no pharmacy may lawfully compound
- State coverage
- 7 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
- Rank100
Ivim Health
Ivim Health is number 100 on the tirzepatide board, carried by its prescriber and intake mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Ivim Health is read on 60% of the rubric's weight: dosing guidance, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank101
Heros Health
Heros Health is number 101 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is stays within legal scope.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists BPC-157, CJC-1295, Ipamorelin, TB-500, Retatrutide, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Heros Health is read on 65% of the rubric's weight: dosing guidance, state coverage and price against the market are left out of its order, not counted against it.
- Rank102
PrescrYbe
PrescrYbe is number 102 on the tirzepatide board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)from $339 per 4 wks$367 a calendar month, our arithmetic
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board PrescrYbe is read on 65% of the rubric's weight: stays within legal scope, state coverage and price as the dose rises are left out of its order, not counted against it.
Compare providers 103–114HealthHub, HealthSource, PrescribedRX, June Health, Tyde Wellness, Apex MD, Mondae, Klinic, ShedRx, Nex Gen Health Rx, Alloy, Gimme Care
- Rank103
HealthHub
HealthHub is number 103 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)from $249/mo
- Tirzepatide oral (compounded)from $199/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board HealthHub is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank104
HealthSource
HealthSource is number 104 on the tirzepatide board, carried by its prescriber and intake mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $299 per 4 wks$324 a calendar month, our arithmetic
- Tirzepatide sublingual (compounded)from $399 per 4 wks$432 a calendar month, our arithmetic
- Prescriber and intake
- Names its physician network; a consultation before any prescription
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board HealthSource is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank105
PrescribedRX
PrescribedRX is number 105 on the tirzepatide board, carried by its prescriber and intake mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $276/mo$420 a calendar month, our arithmetic
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board PrescribedRX is read on 70% of the rubric's weight: dosing guidance and state coverage are left out of its order, not counted against it.
- Rank106
June Health
June Health is number 106 on the tirzepatide board, carried by its prescriber and intake mark and its dosing guidance mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $409/mo
- Tirzepatide oral (compounded)from $249/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
On the tirzepatide board June Health is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank107
Tyde Wellness
Tyde Wellness is number 107 on the tirzepatide board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)from $349/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank108
Apex MD
Apex MD is number 108 on the tirzepatide board, carried by its follow-up mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $399/mo
- Tirzepatide oral (compounded)price not published
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Apex MD is read on 75% of the rubric's weight: dosing guidance is left out of its order, not counted against it.
- Rank109
Mondae
Mondae is number 109 on the tirzepatide board, carried by its prescriber and intake mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $126/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
- Rank110
Klinic
Klinic is number 110 on the tirzepatide board, carried by its prescriber and intake mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
Tirzepatide is on Klinic's own list with no price we hold.
- Prescriber and intake
- Names its physician network; a consultation before any prescription
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Klinic is read on 50% of the rubric's weight: dosing guidance, follow-up, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank111
ShedRx
ShedRx is number 111 on the tirzepatide board, carried by its prescriber and intake mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board ShedRx is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank112
Nex Gen Health Rx
Nex Gen Health Rx is number 112 on the tirzepatide board, carried by its pharmacy named mark and its dosing guidance mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)from $239/mo
- Prescriber and intake
- Names no prescriber
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Nex Gen Health Rx is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank113
Alloy
Alloy is number 113 on the tirzepatide board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)from $100/mo$199 a month with the required membership, our total
- Tirzepatide injection (brand)from $299/mo$398 a month with the required membership, our total
- Prescriber and intake
- Names one prescribing physician; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Alloy is read on 65% of the rubric's weight: stays within legal scope, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank114
Gimme Care
Gimme Care is number 114 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $199/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
Compare providers 115–126AHBARx, Kin Meds, HealthOn, Found Youth, EllieMD, Actin, Harbor, Maximus, Goldspan Health, WePeptideRx, Nucific, Brightmeds
- Rank115
AHBARx
AHBARx is number 115 on the tirzepatide board, carried by its prescriber and intake mark and its pharmacy named mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)from $349/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists Oxytocin, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board AHBARx is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank116
Kin Meds
Kin Meds is number 116 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (brand)price not published
- Tirzepatide injection (compounded)from $249/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Kin Meds is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank117
HealthOn
HealthOn is number 117 on the tirzepatide board, carried by its prescriber and intake mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board HealthOn is read on 60% of the rubric's weight: dosing guidance, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank118
Found Youth
Found Youth is number 118 on the tirzepatide board, carried by its pharmacy named mark and its follow-up mark.
- What it prices here
- Tirzepatide injection (compounded)from $329/mo
- Tirzepatide sublingual (compounded)from $249/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists Oxytocin, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Found Youth is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank119
EllieMD
EllieMD is number 119 on the tirzepatide board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is stays within legal scope.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists Epitalon, Thymosin alpha-1, Melanotan II, Semax, Selank, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board EllieMD is read on 60% of the rubric's weight: dosing guidance, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank120
Actin
Actin is number 120 on the tirzepatide board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is stays within legal scope.
- What it prices here
- Tirzepatide injection (compounded)from $269/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Also lists CJC-1295, Ipamorelin, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Actin is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank121
Harbor
Harbor is number 121 on the tirzepatide board, carried by its follow-up mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $149/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Harbor is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank122
Maximus
Maximus is number 122 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Tirzepatide injection (brand)from $549.99/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank123
Goldspan Health
Goldspan Health is number 123 on the tirzepatide board, carried by its follow-up mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $299 for 4 weeks$324 a calendar month, our arithmetic
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Goldspan Health is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank124
WePeptideRx
WePeptideRx is number 124 on the tirzepatide board, carried by its dosing guidance mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $159/mo
- Tirzepatide injection (brand)from $659/mo
- Prescriber and intake
- Names one prescribing physician; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board WePeptideRx is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank125
Nucific
Nucific is number 125 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
Tirzepatide is on Nucific's own list with no price we hold.
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Nucific is read on 60% of the rubric's weight: dosing guidance, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank126
Brightmeds
Brightmeds is number 126 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)from $149/mo
- Tirzepatide injection (brand)price not published
- Prescriber and intake
- Names no prescriber; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 47 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
Compare providers 127–138Citizen Meds, Regenics, NuBloom, Rehydra+ Wellness, LifeVine Wellness, Good Girl Rx, Ascend Vitality, NiceRx, AgelessRx, Fitish, Joi + Blokes, Alan Meds
- Rank127
Citizen Meds
Citizen Meds is number 127 on the tirzepatide board, carried by its dosing guidance mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $145 per 4 wks$157 a calendar month, our arithmetic
- Prescriber and intake
- Not recorded: our review found no answer on its pages
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
On the tirzepatide board Citizen Meds is read on 45% of the rubric's weight: prescriber and intake, follow-up and state coverage are left out of its order, not counted against it.
- Rank128
Regenics
Regenics is number 128 on the tirzepatide board, carried by its prescriber and intake mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $199/mo$278 a month with the required membership, our total
- Prescriber and intake
- Names one prescribing physician; a consultation before any prescription
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Regenics is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank129
NuBloom
NuBloom is number 129 on the tirzepatide board, carried by its dosing guidance mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $279/mo
- Prescriber and intake
- Names one prescribing physician; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 49 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board NuBloom is read on 70% of the rubric's weight: follow-up and price as the dose rises are left out of its order, not counted against it.
- Rank130
Rehydra+ Wellness
Rehydra+ Wellness is number 130 on the tirzepatide board, carried by its prescriber and intake mark and its dosing guidance mark; its weakest mark here is stays within legal scope.
- What it prices here
- Tirzepatide injection (compounded)from $219 per 4 wks$237 a calendar month, our arithmetic
- Prescriber and intake
- Names its prescribing doctors
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists MOTS-c, BPC-157, TB-500, KPV, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
On the tirzepatide board Rehydra+ Wellness is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank131
LifeVine Wellness
LifeVine Wellness is number 131 on the tirzepatide board, carried by its prescriber and intake mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $347/mo
- Prescriber and intake
- Names its physician network
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board LifeVine Wellness is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank132
Good Girl Rx
Good Girl Rx is number 132 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $329/mo
- Tirzepatide oral (compounded)from $397/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Good Girl Rx is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank133
Ascend Vitality
Ascend Vitality is number 133 on the tirzepatide board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is stays within legal scope.
- What it prices here
- Tirzepatide injection (compounded)from $249/mo
- Tirzepatide oral (compounded)price not published
- Prescriber and intake
- Names its physician network; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Also lists BPC-157, CJC-1295, Ipamorelin, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Ascend Vitality is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank134
NiceRx
NiceRx is number 134 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Prescriber and intake
- Names no prescriber; a consultation before any prescription
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 46 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board NiceRx is read on 75% of the rubric's weight: dosing guidance is left out of its order, not counted against it.
- Rank135
AgelessRx
AgelessRx is number 135 on the tirzepatide board, carried by its prescriber and intake mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Tirzepatide injection (brand)from $514/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board AgelessRx is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank136
Fitish
Fitish is number 136 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $339/mo
- Tirzepatide sublingual (compounded)from $339 per 4 wks$367 a calendar month, our arithmetic
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Fitish is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank137
Joi + Blokes
Joi + Blokes is number 137 on the tirzepatide board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Also lists Oxytocin, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Joi + Blokes is read on 70% of the rubric's weight: state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank138
Alan Meds
Alan Meds is number 138 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names its physician network; a questionnaire, with no live visit mentioned
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 46 states
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Alan Meds is read on 70% of the rubric's weight: dosing guidance and price against the market are left out of its order, not counted against it.
Compare providers 139–150RxPepsDirect, Pomegranate Health, Genesis Health, Bayan Health, TrueMe, He & She MD, TeleZen MD, GobyMeds, Amble, Lumora, FormBlends, Longevixx
- Rank139
RxPepsDirect
RxPepsDirect is number 139 on the tirzepatide board, carried by its prescriber and intake mark and its dosing guidance mark; its weakest mark here is stays within legal scope.
- What it prices here
- Tirzepatide injection (compounded)from $45/mo$99 a month with the required consult and shipping, our total
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists MOTS-c, BPC-157, Kisspeptin, Ipamorelin, Epitalon, DSIP, TB-500, MK-677, Oxytocin, KPV, AOD-9604, Semax, Selank, SS-31, 5-Amino-1MQ, which no pharmacy may lawfully compound
- State coverage
- 29 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board RxPepsDirect is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank140
Pomegranate Health
Pomegranate Health is number 140 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)from $159/mo
- Prescriber and intake
- Names no prescriber
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
On the tirzepatide board Pomegranate Health is read on 70% of the rubric's weight: dosing guidance and state coverage are left out of its order, not counted against it.
- Rank141
Genesis Health
Genesis Health is number 141 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $225/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Genesis Health is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank142
Bayan Health
Bayan Health is number 142 on the tirzepatide board, carried by its follow-up mark and its price as the dose rises mark; its weakest mark here is stays within legal scope.
- What it prices here
- Tirzepatide injection (compounded)from $149/mo
- Tirzepatide oral (compounded)price not published
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Not recorded: our review found no answer on its pages
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists MOTS-c, BPC-157, Epitalon, TB-500, Thymosin alpha-1, Oxytocin, KPV, Semax, Selank, SS-31, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Bayan Health is read on 65% of the rubric's weight: pharmacy named and state coverage are left out of its order, not counted against it.
- Rank143
TrueMe
TrueMe is number 143 on the tirzepatide board, carried by its pharmacy named mark and its stays within legal scope mark; its weakest mark here is dosing guidance.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- 6 states
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Same price at every dose
On the tirzepatide board TrueMe is read on 70% of the rubric's weight: follow-up and price against the market are left out of its order, not counted against it.
- Rank144
He & She MD
He & She MD is number 144 on the tirzepatide board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Tirzepatide oral (compounded)from $339/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with no live visit mentioned
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists MOTS-c, which no pharmacy may lawfully compound
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board He & She MD is read on 70% of the rubric's weight: dosing guidance and price as the dose rises are left out of its order, not counted against it.
- Rank145
TeleZen MD
TeleZen MD is number 145 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $268/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with no live visit mentioned
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board TeleZen MD is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank146
GobyMeds
GobyMeds is number 146 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board GobyMeds is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank147
Amble
Amble is number 147 on the tirzepatide board, carried by its follow-up mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $329/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
- Rank148
Lumora
Lumora is number 148 on the tirzepatide board, carried by its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Tirzepatide sublingual (compounded)price not published
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Lumora is read on 50% of the rubric's weight: dosing guidance, follow-up, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank149
FormBlends
FormBlends is number 149 on the tirzepatide board, carried by its pharmacy named mark and its follow-up mark; its weakest mark here is stays within legal scope.
- What it prices here
- Tirzepatide injection (compounded)from $214/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Names its compounding pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Also lists MOTS-c, BPC-157, CJC-1295, Ipamorelin, Epitalon, DSIP, TB-500, Oxytocin, KPV, AOD-9604, Semax, Selank, LL-37, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board FormBlends is read on 65% of the rubric's weight: dosing guidance, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank150
Longevixx
Longevixx is number 150 on the tirzepatide board, carried by its follow-up mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $149/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with no live visit mentioned
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Longevixx is read on 75% of the rubric's weight: dosing guidance is left out of its order, not counted against it.
Compare providers 151–162Nova, LaSara Medical Group, Stealth Health, Immortals, Alternate Health Club, AskRx, TelePeptide, Andrew Meds, Iron Med RX, VitaStir, ReadyRx, Arc-1
- Rank151
Nova
Nova is number 151 on the tirzepatide board, carried by its follow-up mark and its state coverage mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $279/mo
- Tirzepatide sublingual (compounded)from $174/mo
- Prescriber and intake
- Not recorded: our review found no answer on its pages
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Also lists Oxytocin, which no pharmacy may lawfully compound
- State coverage
- 49 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
On the tirzepatide board Nova is read on 50% of the rubric's weight: prescriber and intake and dosing guidance are left out of its order, not counted against it.
- Rank152
LaSara Medical Group
LaSara Medical Group is number 152 on the tirzepatide board, carried by its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $379/mo
- Tirzepatide topical (compounded)from $379/mo
- Prescriber and intake
- Names its prescribing doctors; a questionnaire, with no live visit mentioned
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board LaSara Medical Group is read on 65% of the rubric's weight: follow-up, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank153
Stealth Health
Stealth Health is number 153 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
Tirzepatide is on Stealth Health's own list with no price we hold.
- Prescriber and intake
- Not recorded: our review found no answer on its pages
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Stealth Health is read on 35% of the rubric's weight: prescriber and intake, dosing guidance, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank154
Immortals
Immortals is number 154 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $255/mo
- Prescriber and intake
- A questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Immortals is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank155
Alternate Health Club
Alternate Health Club is number 155 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $169/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Alternate Health Club is read on 80% of the rubric's weight: state coverage is left out of its order, not counted against it.
- Rank156
AskRx
AskRx is number 156 on the tirzepatide board, carried by its dosing guidance mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (brand)from $299/mo$399 a month with the required consult, our total
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board AskRx is read on 70% of the rubric's weight: stays within legal scope and price as the dose rises are left out of its order, not counted against it.
- Rank157
TelePeptide
TelePeptide is number 157 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $249/mo
- Tirzepatide oral (compounded)from $249/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board TelePeptide is read on 70% of the rubric's weight: dosing guidance and state coverage are left out of its order, not counted against it.
- Rank158
Andrew Meds
Andrew Meds is number 158 on the tirzepatide board, carried by its follow-up mark and its state coverage mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists CJC-1295, Ipamorelin, which no pharmacy may lawfully compound
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Andrew Meds is read on 80% of the rubric's weight: price as the dose rises is left out of its order, not counted against it.
- Rank159
Iron Med RX
Iron Med RX is number 159 on the tirzepatide board, carried by its follow-up mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $149/mo
- Tirzepatide oral (compounded)from $249/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Iron Med RX is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank160
VitaStir
VitaStir is number 160 on the tirzepatide board, carried by its dosing guidance mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $145 for 4 weeks$157 a calendar month, our arithmetic
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: strength and schedule printed
- Follow-up
- No follow-up stated
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board VitaStir is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank161
ReadyRx
ReadyRx is number 161 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $315/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with no live visit mentioned
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board ReadyRx is read on 70% of the rubric's weight: dosing guidance and price as the dose rises are left out of its order, not counted against it.
- Rank162
Arc-1
Arc-1 is number 162 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $199.99/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Price rises with the dose
On the tirzepatide board Arc-1 is read on 70% of the rubric's weight: dosing guidance and state coverage are left out of its order, not counted against it.
Compare providers 163–174Ark Health, ElleS, Concierge MD LA, Rylo Health, Push Health, YourHealthRx, Meto, Glam Health, Rewinding RX, TrimRx, Yes Clinic, ElitePhysiqMD
- Rank163
Ark Health
Ark Health is number 163 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $249/mo
- Prescriber and intake
- Names its physician network; a questionnaire, with no live visit mentioned
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Ark Health is read on 75% of the rubric's weight: state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank164
ElleS
ElleS is number 164 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Tirzepatide oral (compounded)price not published
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board ElleS is read on 60% of the rubric's weight: dosing guidance, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank165
Concierge MD LA
Concierge MD LA is number 165 on the tirzepatide board, carried by its prescriber and intake mark; its weakest mark here is stays within legal scope.
- What it prices here
- Tirzepatide injection (compounded)from $299/mo
- Tirzepatide injection (brand)from $1,999/mo
- Prescriber and intake
- Names its physician network; a consultation before any prescription
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Also lists BPC-157, CJC-1295, Ipamorelin, Thymosin alpha-1, Oxytocin, Semax, Selank, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Concierge MD LA is read on 55% of the rubric's weight: dosing guidance, follow-up, state coverage and price as the dose rises are left out of its order, not counted against it.
- Rank166
Rylo Health
Rylo Health is number 166 on the tirzepatide board, carried by its follow-up mark and its state coverage mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $229/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with no live visit mentioned
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Also lists MOTS-c, which no pharmacy may lawfully compound
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Rylo Health is read on 75% of the rubric's weight: dosing guidance is left out of its order, not counted against it.
- Rank167
Push Health
Push Health is number 167 on the tirzepatide board, carried by its stays within legal scope mark; its weakest mark here is prescriber and intake.
- What it prices here
Tirzepatide is on Push Health's own list with no price we hold.
- Prescriber and intake
- Names no prescriber; a questionnaire, with no live visit mentioned
- Pharmacy named
- Not recorded: our review found no answer on its pages
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Push Health is read on 35% of the rubric's weight: pharmacy named, dosing guidance, follow-up, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank168
YourHealthRx
YourHealthRx is number 168 on the tirzepatide board, carried by its stays within legal scope mark and its follow-up mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)from $210/mo
- Tirzepatide oral (compounded)from $220/mo
- Prescriber and intake
- Names no prescriber
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Ongoing access to a provider included
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
- Rank169
Meto
Meto is number 169 on the tirzepatide board, carried by its follow-up mark and its stays within legal scope mark; its weakest mark here is prescriber and intake.
- What it prices here
Tirzepatide is on Meto's own list with no price we hold.
- Prescriber and intake
- Names no prescriber
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Meto is read on 60% of the rubric's weight: dosing guidance, state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank170
Glam Health
Glam Health is number 170 on the tirzepatide board, carried by its follow-up mark and its stays within legal scope mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names no prescriber; a questionnaire, with no live visit mentioned
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Scheduled check-ins, with messaging
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Glam Health is read on 70% of the rubric's weight: state coverage, price against the market and price as the dose rises are left out of its order, not counted against it.
- Rank171
Rewinding RX
Rewinding RX is number 171 on the tirzepatide board, carried by its follow-up mark and its state coverage mark; its weakest mark here is stays within legal scope.
- What it prices here
- Tirzepatide injection (compounded)from $189/mo
- Tirzepatide sublingual (compounded)from $169/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with no live visit mentioned
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Also lists MOTS-c, BPC-157, TB-500, which no pharmacy may lawfully compound
- State coverage
- All 50 states
- Price against the market
- At or below the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Rewinding RX is read on 75% of the rubric's weight: dosing guidance is left out of its order, not counted against it.
- Rank172
TrimRx
TrimRx is number 172 on the tirzepatide board, carried by its follow-up mark and its price as the dose rises mark; its weakest mark here is pharmacy named.
- What it prices here
- Tirzepatide injection (compounded)from $399/mo
- Prescriber and intake
- Names no prescriber; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: no dose printed
- Follow-up
- Unlimited follow-ups, free
- Stays within legal scope
- Not recorded: our review found no answer on its pages
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Same price at every dose
On the tirzepatide board TrimRx is read on 70% of the rubric's weight: stays within legal scope and state coverage are left out of its order, not counted against it.
- Rank173
Yes Clinic
Yes Clinic is number 173 on the tirzepatide board, carried by its stays within legal scope mark and its price as the dose rises mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Prescriber and intake
- Names no prescriber
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Tirzepatide: schedule printed, no strength
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Not recorded: no monthly price in this scope
- Price as the dose rises
- Same price at every dose
On the tirzepatide board Yes Clinic is read on 65% of the rubric's weight: follow-up, state coverage and price against the market are left out of its order, not counted against it.
- Rank174
ElitePhysiqMD
ElitePhysiqMD is number 174 on the tirzepatide board; its weakest mark here is stays within legal scope.
- What it prices here
- Tirzepatide injection (compounded)from $224.10/mo$313.10 a month with the required membership, our total
- Prescriber and intake
- Names one prescribing physician; a questionnaire, with a live visit available or required in some states
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Also lists MOTS-c, BPC-157, Kisspeptin, CJC-1295, Ipamorelin, Epitalon, DSIP, TB-500, Semax, Selank, which no pharmacy may lawfully compound
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Price rises with the dose
On the tirzepatide board ElitePhysiqMD is read on 60% of the rubric's weight: dosing guidance, follow-up and state coverage are left out of its order, not counted against it.
Compare providers 175–175Loop Health
- Rank175
Loop Health
Loop Health is number 175 on the tirzepatide board, carried by its stays within legal scope mark; its weakest mark here is prescriber and intake.
- What it prices here
- Tirzepatide injection (compounded)price not published
- Tirzepatide oral (compounded)from $399/mo
- Tirzepatide injection (compounded)from $299/mo
- Prescriber and intake
- Names no prescriber
- Pharmacy named
- Does not name its pharmacy
- Dosing guidance
- Not recorded: our review found no answer on its pages
- Follow-up
- Not recorded: our review found no answer on its pages
- Stays within legal scope
- Lists no research-only peptide
- State coverage
- Not recorded: our review found no answer on its pages
- Price against the market
- Above the market's middle
- Price as the dose rises
- Not recorded: not established from its pages
On the tirzepatide board Loop Health is read on 55% of the rubric's weight: dosing guidance, follow-up, state coverage and price as the dose rises are left out of its order, not counted against it.
What the order on this board weighs
On the tirzepatide board 8 of the rubric's 9 marks apply, rescaled to share the whole order between them: prescriber and intake carries 29%, pharmacy named carries 18% and dosing guidance carries 12%. What each mark reads
- 29%
- Prescriber and intake
- 18%
- Pharmacy named
- 12%
- Dosing guidance
- 12%
- Follow-up
- 12%
- Stays within legal scope
- 6%
- State coverage
- 6%
- Price against the market
- 6%
- Price as the dose rises
Whether a seller pays us is not one of the 8 marks on the tirzepatide board, and the rubric cannot read it.
Best compounded tirzepatide prescribers
Frequently asked questions
- How is the tirzepatide board ordered?
- The 31 partners sort first and are labeled; after that the rubric decides. The rubric reads each seller on tirzepatide, and here prescriber and intake carries 29%, pharmacy named carries 18% and dosing guidance carries 12%.
- Do you earn a commission from the sellers on the tirzepatide board?
- On part of it. 31 sellers are partners on the tirzepatide board, labeled Partner where they appear; the rest of the links pay us nothing.
- Which marks are not recorded on the tirzepatide board?
- Not recorded: state coverage and price as the dose rises for SkinnyRx, state coverage for Lttl, follow-up and state coverage for Oak, dosing guidance for Gala, state coverage for YourEra, stays within legal scope, state coverage, price against the market and price as the dose rises for HumeCare+, pharmacy named, dosing guidance, follow-up, state coverage and price as the dose rises for Direct Meds, stays within legal scope and price as the dose rises for Found, price as the dose rises for Sprout Health, price as the dose rises for PeterMD, dosing guidance and price as the dose rises for Embody, stays within legal scope and state coverage for SnagRx, stays within legal scope and price as the dose rises for MEDGm, state coverage for HealthRX, price as the dose rises for Strut Health, dosing guidance for CoreAge Rx, dosing guidance, price against the market and price as the dose rises for Live Vital, state coverage and price as the dose rises for DudeMeds, price as the dose rises for RxSpan MD, pharmacy named, dosing guidance, stays within legal scope and state coverage for Sesame Care, state coverage and price as the dose rises for Bodybuilding Health+, state coverage for Luvo Health, stays within legal scope for Collective, dosing guidance, state coverage and price as the dose rises for Willow, state coverage and price as the dose rises for RNK Health, dosing guidance for Wellorithm, dosing guidance, state coverage and price as the dose rises for MyDrHank, pharmacy named, dosing guidance, state coverage, price against the market and price as the dose rises for Klarity Health, price as the dose rises for PlexusDx, stays within legal scope, state coverage and price as the dose rises for NowPatient, state coverage for Contour Health, dosing guidance and follow-up for Care Bare Rx, pharmacy named, dosing guidance, state coverage, price against the market and price as the dose rises for CVS MinuteClinic, pharmacy named, dosing guidance, state coverage, price against the market and price as the dose rises for Form Health, pharmacy named, dosing guidance, state coverage, price against the market and price as the dose rises for MD Live, pharmacy named, dosing guidance, state coverage, price against the market and price as the dose rises for MEDvidi, state coverage and price as the dose rises for Try Ageless, prescriber and intake, dosing guidance and follow-up for EOS Health, price as the dose rises for Synergy Rx, state coverage and price against the market for RxSaludable, prescriber and intake and state coverage for Levers Health, pharmacy named, dosing guidance, price against the market and price as the dose rises for FuturHealth, price as the dose rises for Ivologist, dosing guidance and state coverage for Obu Health, dosing guidance, price against the market and price as the dose rises for Kova, dosing guidance, follow-up and price as the dose rises for Medro, dosing guidance, state coverage and price as the dose rises for Enhanced, price as the dose rises for REMEVi, stays within legal scope, state coverage and price as the dose rises for Hims, dosing guidance and state coverage for Nova MD, stays within legal scope for Trimi Health, state coverage and price as the dose rises for ARSYNL Rx, state coverage and price as the dose rises for Bloom MD, price as the dose rises for Midi Health, state coverage for Avono Health, dosing guidance, state coverage and price as the dose rises for Fridays, dosing guidance, follow-up and state coverage for Vyora Wellness, price as the dose rises for Vita Bella, stays within legal scope, state coverage, price against the market and price as the dose rises for Zenbody, follow-up for Trellis Vitality, state coverage, price against the market and price as the dose rises for MadeMed, price as the dose rises for Vytora Health, pharmacy named, dosing guidance, state coverage, price against the market and price as the dose rises for Evernow, follow-up, state coverage and price as the dose rises for Woodwork, state coverage for 50 Stars Health, state coverage for RxION Health, follow-up, state coverage and price as the dose rises for Nu Image Medical, pharmacy named, state coverage and price as the dose rises for VigorMeds, state coverage and price as the dose rises for Welludr, price as the dose rises for PepHaūs, price against the market and price as the dose rises for Brello Health, dosing guidance and price as the dose rises for EdgeRx, state coverage for Raeliva, state coverage for PauseRX, state coverage and price as the dose rises for Jently, price as the dose rises for Auren Rx, dosing guidance for Pallas Health, state coverage and price as the dose rises for Whoosh Wellness, state coverage and price as the dose rises for Invigor Medical, pharmacy named, dosing guidance and state coverage for Nurx, price as the dose rises for PreventiveMD, state coverage for iThriveMD, follow-up and price as the dose rises for Breeze Meds, dosing guidance and price as the dose rises for Heally, dosing guidance, state coverage, price against the market and price as the dose rises for Ivim Health, dosing guidance, state coverage and price against the market for Heros Health, stays within legal scope, state coverage and price as the dose rises for PrescrYbe, dosing guidance, state coverage and price as the dose rises for HealthHub, price as the dose rises for HealthSource, dosing guidance and state coverage for PrescribedRX, state coverage for June Health, dosing guidance for Apex MD, dosing guidance, follow-up, state coverage, price against the market and price as the dose rises for Klinic, dosing guidance, state coverage and price as the dose rises for ShedRx, state coverage for Nex Gen Health Rx, stays within legal scope, state coverage and price as the dose rises for Alloy, state coverage and price as the dose rises for AHBARx, state coverage and price as the dose rises for Kin Meds, dosing guidance, state coverage, price against the market and price as the dose rises for HealthOn, state coverage and price as the dose rises for Found Youth, dosing guidance, state coverage, price against the market and price as the dose rises for EllieMD, dosing guidance, state coverage and price as the dose rises for Actin, state coverage and price as the dose rises for Harbor, state coverage for Goldspan Health, state coverage and price as the dose rises for WePeptideRx, dosing guidance, state coverage, price against the market and price as the dose rises for Nucific, prescriber and intake, follow-up and state coverage for Citizen Meds, dosing guidance, state coverage and price as the dose rises for Regenics, follow-up and price as the dose rises for NuBloom, state coverage for Rehydra+ Wellness, price as the dose rises for LifeVine Wellness, dosing guidance, state coverage and price as the dose rises for Good Girl Rx, state coverage and price as the dose rises for Ascend Vitality, dosing guidance for NiceRx, state coverage and price as the dose rises for AgelessRx, price as the dose rises for Fitish, state coverage, price against the market and price as the dose rises for Joi + Blokes, dosing guidance and price against the market for Alan Meds, price as the dose rises for RxPepsDirect, dosing guidance and state coverage for Pomegranate Health, dosing guidance, state coverage and price as the dose rises for Genesis Health, pharmacy named and state coverage for Bayan Health, follow-up and price against the market for TrueMe, dosing guidance and price as the dose rises for He & She MD, dosing guidance, state coverage and price as the dose rises for TeleZen MD, dosing guidance, state coverage and price as the dose rises for GobyMeds, dosing guidance, follow-up, state coverage, price against the market and price as the dose rises for Lumora, dosing guidance, state coverage and price as the dose rises for FormBlends, dosing guidance for Longevixx, prescriber and intake and dosing guidance for Nova, follow-up, state coverage and price as the dose rises for LaSara Medical Group, prescriber and intake, dosing guidance, state coverage, price against the market and price as the dose rises for Stealth Health, state coverage and price as the dose rises for Immortals, state coverage for Alternate Health Club, stays within legal scope and price as the dose rises for AskRx, dosing guidance and state coverage for TelePeptide, price as the dose rises for Andrew Meds, state coverage and price as the dose rises for Iron Med RX, state coverage and price as the dose rises for VitaStir, dosing guidance and price as the dose rises for ReadyRx, dosing guidance and state coverage for Arc-1, state coverage and price as the dose rises for Ark Health, dosing guidance, state coverage, price against the market and price as the dose rises for ElleS, dosing guidance, follow-up, state coverage and price as the dose rises for Concierge MD LA, dosing guidance for Rylo Health, pharmacy named, dosing guidance, follow-up, state coverage, price against the market and price as the dose rises for Push Health, dosing guidance, state coverage, price against the market and price as the dose rises for Meto, state coverage, price against the market and price as the dose rises for Glam Health, dosing guidance for Rewinding RX, stays within legal scope and state coverage for TrimRx, follow-up, state coverage and price against the market for Yes Clinic, dosing guidance, follow-up and state coverage for ElitePhysiqMD and dosing guidance, follow-up, state coverage and price as the dose rises for Loop Health. Each is left out of that seller's order on this board, because our review of its pages found no answer, and the seller's other marks carry its place instead.
- Which sellers of tirzepatide are not on this board?
- 230 more sellers on our roster publish a price for tirzepatide and are not ranked on the tirzepatide board until we publish a review of each one.